Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.27 USD | -2.39% | -3.54% | -38.88% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
Business Summary
Number of employees: 404
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Instruments, Equipment, Software and Accessories
94.2
%
| 108 | 95.4 % | 106 | 94.2 % | -2.26% |
Service, Maintenance and Warranty Contracts
5.8
%
| 5 | 4.6 % | 7 | 5.8 % | +26.38% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
42.9
%
| 50 | 44.0 % | 48 | 42.9 % | -3.42% |
Europe
29.2
%
| 31 | 27.1 % | 33 | 29.2 % | +6.89% |
Greater China
16.5
%
| 16 | 14.5 % | 18 | 16.5 % | +12.78% |
Rest of the World
11.4
%
| 16 | 14.4 % | 13 | 11.4 % | -21.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Nitya Shetty
PRN | Corporate Officer/Principal | - | 21-09-30 |
Ryan Wallace
SAM | Sales & Marketing | - | 19-12-31 |
John Fry
LAW | General Counsel | 62 | 22-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Thomas Loewald
BRD | Director/Board Member | 61 | 17-10-23 |
Katherine Eade
BRD | Director/Board Member | 50 | 17-10-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,429,626 | 40,266,395 ( 92.72 %) | 0 | 92.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
697,112 | 5.00% | 1,666,098 $ |
Company contact information
Harvard Bioscience, Inc.
84 October Hill Road Suite 10
01746-1371, Holliston
+508 893 8999
http://www.harvardbioscience.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.88% | 142M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.30% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- HBIO Stock
- Company Harvard Bioscience, Inc.